Home / Resource Library / Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era

Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era

Study examined outcomes of patients with extranodal DLBCL treated with rituximab.